EGL-27 Activators would refer to a group of compounds that specifically enhance the activity of the EGL-27 protein. EGL-27 is part of the conserved group of proteins known to associate with chromatin and influence gene expression through epigenetic mechanisms. In the model organism Caenorhabditis elegans, from which the EGL-27 nomenclature arises, this protein has been implicated in the regulation of developmental processes and the maintenance of cell-type specific gene expression patterns. Activators of EGL-27 would, therefore, be expected to modulate the epigenetic landscape, potentially by promoting the association of EGL-27 with chromatin or by enhancing its interaction with other epigenetic factors like histones or transcription regulators. The exact mode of action of these activators would depend on the structural domains of EGL-27 that are critical for its function and how these domains interact with the chromatin substrate.
To understand the impact and mechanism of action of EGL-27 activators, a suite of experimental techniques would be necessary. Biochemical assays could be employed to analyze the binding affinity of these activators to EGL-27 and to test whether they affect the protein's ability to interact with chromatin or modify histones. For example, one might use chromatin immunoprecipitation (ChIP) to determine if the presence of activators alters the binding pattern of EGL-27 on the genome. On a broader scale, researchers could utilize transcriptomic analyses, such as RNA sequencing, to observe changes in gene expression profiles consequent to EGL-27 activation. This would help to delineate the downstream effects of EGL-27 on gene regulatory networks. Additionally, more direct assays, like reporter gene assays, could be used to examine the influence of EGL-27 activators on the expression of specific target genes. Through these diverse approaches, the functional role of EGL-27 in gene regulation could be explored in greater depth, providing insights into how activating this protein affects cellular epigenetic states and gene expression outcomes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A DNA methylation inhibitor that might lead to gene reactivation, potentially affecting the expression of genes including EGL-27. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
An HDAC inhibitor that may increase histone acetylation and therefore enhance the expression of multiple genes, possibly including EGL-27. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
A natural product known to modulate epigenetic marks, which could hypothetically influence EGL-27 expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
A polyphenolic compound that affects various signaling pathways and potentially alters gene expression patterns, possibly affecting EGL-27. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
As an HDAC inhibitor, it may upregulate gene expression by increasing histone acetylation, potentially influencing EGL-27 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
An HDAC inhibitor that could relax chromatin structure and lead to increased expression of certain genes, including possibly EGL-27. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Used to modulate proteasome activity, it could affect protein turnover and potentially influence the expression of EGL-27. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $126.00 $278.00 $984.00 | 3 | |
A DNA methylation inhibitor that might activate silent genes, potentially increasing the expression of EGL-27. | ||||||
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $41.00 $53.00 | 3 | |
Another HDAC inhibitor that might enhance acetylation of histones and affect gene expression, possibly impacting EGL-27 levels. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
A catechin from green tea with epigenetic modulating activity that may affect gene expression, potentially influencing EGL-27. | ||||||